Bone Marrow Disease News and Research

RSS
FDA approves Sprycel for treatment of adults with Ph+ CP-CML

FDA approves Sprycel for treatment of adults with Ph+ CP-CML

Mesoblast broadens cancer indications for bone marrow transplant product

Mesoblast broadens cancer indications for bone marrow transplant product

BioCryst reports results from forodesine studies for CTCL and CLL

BioCryst reports results from forodesine studies for CTCL and CLL

EpiCept second-quarter net loss decreases to $4.9 million

EpiCept second-quarter net loss decreases to $4.9 million

FDA approves new indication for Tasigna in treatment of rare blood cancer

FDA approves new indication for Tasigna in treatment of rare blood cancer

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

EpiCept provides update on corporate strategy, reports net loss of $4.5M for first-quarter 2010

EpiCept provides business update and fourth-quarter financial highlights

EpiCept provides business update and fourth-quarter financial highlights

Update on new clinical developments and other initiatives related to Ceplene

Update on new clinical developments and other initiatives related to Ceplene

New treatment options for leukemia and myeloproliferative disorders introduced

New treatment options for leukemia and myeloproliferative disorders introduced

EpiCept announces third quarter 2009 financial results

EpiCept announces third quarter 2009 financial results

Researchers find new ways to treat Myelodysplastic Syndrome

Researchers find new ways to treat Myelodysplastic Syndrome

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

FDA approves TREANDA (bendamustine hydrochloride) for chronic lymphocytic leukemia

FDA grants orphan drug designation to TREANDA

FDA grants orphan drug designation to TREANDA

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

Study recommends treatment change for pre-leukemia disease

Study recommends treatment change for pre-leukemia disease

Decitabine improves patient outcomes in myelodysplastic syndromes

Decitabine improves patient outcomes in myelodysplastic syndromes

FDA approves new drug for bone marrow disease

FDA approves new drug for bone marrow disease